HEADER OXIDOREDUCTASE 17-OCT-21 7SJG TITLE STRUCTURE OF DEHALOPEROXIDASE B IN COMPLEX WITH THYMOQUINONE CAVEAT 7SJG 9J9 A 205 HAS WRONG CHIRALITY AT ATOM C1 9J9 A 207 HAS WRONG CAVEAT 2 7SJG CHIRALITY AT ATOM C1 9J9 A 208 HAS WRONG CHIRALITY AT ATOM CAVEAT 3 7SJG C1 9J9 B 205 HAS WRONG CHIRALITY AT ATOM C1 COMPND MOL_ID: 1; COMPND 2 MOLECULE: DEHALOPEROXIDASE B; COMPND 3 CHAIN: A, B; COMPND 4 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: AMPHITRITE ORNATA; SOURCE 3 ORGANISM_TAXID: 129555; SOURCE 4 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21; SOURCE 5 EXPRESSION_SYSTEM_TAXID: 511693; SOURCE 6 EXPRESSION_SYSTEM_VARIANT: GOLD(DE3) KEYWDS HEME PEROXIDASE, PEROXYGENASE, HEME COFACTOR, OXYGEN BINDING, KEYWDS 2 OXIDOREDUCTASE EXPDTA X-RAY DIFFRACTION AUTHOR R.A.GHILADI,V.S.DE SERRANO,T.MALEWSCHIK,D.YUN REVDAT 2 18-OCT-23 7SJG 1 REMARK REVDAT 1 23-NOV-22 7SJG 0 JRNL AUTH T.MALEWSCHICK,D.YUN,V.DE SERRANO,R.A.GHILADI JRNL TITL THE MULTIFUNCTIONAL GLOBIN DEHALOPEROXIDASE AS A BIOCATALYST JRNL TITL 2 IN THE OXIDATION OF MONOTERPENES JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 1.40 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.8.0267 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.40 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 44.20 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 3 NUMBER OF REFLECTIONS : 53478 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : NULL REMARK 3 R VALUE (WORKING + TEST SET) : NULL REMARK 3 R VALUE (WORKING SET) : 0.142 REMARK 3 FREE R VALUE : 0.195 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.023 REMARK 3 FREE R VALUE TEST SET COUNT : 2686 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.40 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.44 REMARK 3 REFLECTION IN BIN (WORKING SET) : 3750 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.87 REMARK 3 BIN R VALUE (WORKING SET) : 0.2380 REMARK 3 BIN FREE R VALUE SET COUNT : 166 REMARK 3 BIN FREE R VALUE : 0.2790 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2133 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 204 REMARK 3 SOLVENT ATOMS : 208 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 21.02 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 2.29400 REMARK 3 B22 (A**2) : -3.37900 REMARK 3 B33 (A**2) : 1.08500 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.074 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.068 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.058 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 3.415 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.975 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.959 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 2978 ; 0.018 ; 0.013 REMARK 3 BOND LENGTHS OTHERS (A): 2689 ; 0.004 ; 0.015 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 4112 ; 2.258 ; 1.697 REMARK 3 BOND ANGLES OTHERS (DEGREES): 6244 ; 1.704 ; 1.660 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 397 ; 6.005 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 158 ;36.051 ;23.671 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 517 ;17.134 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 16 ;22.573 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 354 ; 0.119 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 3896 ; 0.013 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 748 ; 0.006 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 927 ; 0.295 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): 132 ; 0.296 ; 0.200 REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 1414 ; 0.194 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 194 ; 0.211 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1385 ; 3.714 ; 1.820 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 1386 ; 3.713 ; 1.821 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 1810 ; 4.501 ; 2.755 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): 1811 ; 4.505 ; 2.758 REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1593 ; 8.884 ; 2.372 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): 1586 ; 8.901 ; 2.375 REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 2281 ; 9.995 ; 3.387 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): 2269 ;10.011 ; 3.387 REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): 5667 ; 5.314 ; 3.000 REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK BULK SOLVENT REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THEIR REMARK 3 RIDING POSITIONS REMARK 4 REMARK 4 7SJG COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 18-OCT-21. REMARK 100 THE DEPOSITION ID IS D_1000260412. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 31-JUL-21 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 22-BM REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.000 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : RAYONIX MX300-HS REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 53478 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.400 REMARK 200 RESOLUTION RANGE LOW (A) : 44.200 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 200 DATA REDUNDANCY : 4.700 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 17.1000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.40 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.44 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 3IXF REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 43.28 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.17 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: MPEG 2000, AMMONIUM SULFATE, NA REMARK 280 CACODYLATE, PH 6.5, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE REMARK 280 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 29.17900 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 33.91250 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 33.78250 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 33.91250 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 29.17900 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 33.78250 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ARG A 33 CD NE CZ NH1 NH2 REMARK 470 LYS A 36 CD CE NZ REMARK 470 LYS A 51 CD CE NZ REMARK 470 LYS A 58 CE NZ REMARK 470 LYS A 87 CD CE NZ REMARK 470 LYS A 137 CD CE NZ REMARK 470 ARG B 33 CG CD NE CZ NH1 NH2 REMARK 470 LYS B 47 NZ REMARK 470 LYS B 137 CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OD1 ASP A 30 O1 9J9 A 208 1.81 REMARK 500 OG1 THR B 93 C3 GOL B 204 1.82 REMARK 500 NZ LYS A 47 O HOH A 302 1.95 REMARK 500 O2A HEM B 201 O HOH B 301 2.01 REMARK 500 O MET B 86 O HOH B 302 2.03 REMARK 500 NH1 ARG A 10 O1 GOL A 204 2.09 REMARK 500 NE2 HIS A 89 FE HEM A 201 2.12 REMARK 500 OD1 ASP A 30 C6 9J9 A 208 2.18 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ARG B 10 NE - CZ - NH2 ANGL. DEV. = -5.7 DEGREES REMARK 500 ASN B 37 CB - CA - C ANGL. DEV. = 12.6 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 12 56.47 -144.82 REMARK 500 LYS A 32 39.86 -70.14 REMARK 500 PHE A 35 77.19 -151.00 REMARK 500 SER A 114 46.64 -85.33 REMARK 500 SER A 114 45.11 -95.59 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 GLY B 112 GLN B 113 -141.95 REMARK 500 REMARK 500 REMARK: NULL REMARK 999 REMARK 999 SEQUENCE REMARK 999 LIGAND 9J9 OCCUPIES DENSITY THAT IS CLOSE TO THE POSITION OF H55 IN REMARK 999 ITS ALTERNATE CONFORMATION. THE OCCUPANCIES OF THE ALTERNATE REMARK 999 CONFORMATIONS REFLECT THE FACT. IN THE FRACTION WHERE THE LIGAND IS REMARK 999 BOUND, REFLECTED BY THE OCCUPANCY OF THE LIGAND, H55 IS IN THE REMARK 999 CONFORMATION FACING OUTSIDE OF THE DISTAL SIDE OF THE HEME POCKET, REMARK 999 WITH THE SAME OCCUPANCY AS THE BOUND LIGAND. WHEN THE LIGAND IS NOT REMARK 999 BOUND, H55 CAN OCCUPY THE INSIDE CONFORMATION, ALSO REFLECTED BY REMARK 999 ITS OCCUPANCY. DBREF 7SJG A 1 137 UNP Q9NAV7 Q9NAV7_9ANNE 2 138 DBREF 7SJG B 1 137 UNP Q9NAV7 Q9NAV7_9ANNE 2 138 SEQRES 1 A 137 GLY PHE LYS GLN ASP ILE ALA THR LEU ARG GLY ASP LEU SEQRES 2 A 137 ARG THR TYR ALA GLN ASP ILE PHE LEU ALA PHE LEU ASN SEQRES 3 A 137 LYS TYR PRO ASP GLU LYS ARG ASN PHE LYS ASN TYR VAL SEQRES 4 A 137 GLY LYS SER ASP GLN GLU LEU LYS SER MET ALA LYS PHE SEQRES 5 A 137 GLY ASP HIS THR GLU LYS VAL PHE ASN LEU MET MET GLU SEQRES 6 A 137 VAL ALA ASP ARG ALA THR ASP CYS VAL PRO LEU ALA SER SEQRES 7 A 137 ASP ALA SER THR LEU VAL GLN MET LYS GLN HIS SER GLY SEQRES 8 A 137 LEU THR THR GLY ASN PHE GLU LYS LEU PHE VAL ALA LEU SEQRES 9 A 137 VAL GLU TYR MET ARG ALA SER GLY GLN SER PHE ASP SER SEQRES 10 A 137 GLN SER TRP ASP ARG PHE GLY LYS ASN LEU VAL SER ALA SEQRES 11 A 137 LEU SER SER ALA GLY MET LYS SEQRES 1 B 137 GLY PHE LYS GLN ASP ILE ALA THR LEU ARG GLY ASP LEU SEQRES 2 B 137 ARG THR TYR ALA GLN ASP ILE PHE LEU ALA PHE LEU ASN SEQRES 3 B 137 LYS TYR PRO ASP GLU LYS ARG ASN PHE LYS ASN TYR VAL SEQRES 4 B 137 GLY LYS SER ASP GLN GLU LEU LYS SER MET ALA LYS PHE SEQRES 5 B 137 GLY ASP HIS THR GLU LYS VAL PHE ASN LEU MET MET GLU SEQRES 6 B 137 VAL ALA ASP ARG ALA THR ASP CYS VAL PRO LEU ALA SER SEQRES 7 B 137 ASP ALA SER THR LEU VAL GLN MET LYS GLN HIS SER GLY SEQRES 8 B 137 LEU THR THR GLY ASN PHE GLU LYS LEU PHE VAL ALA LEU SEQRES 9 B 137 VAL GLU TYR MET ARG ALA SER GLY GLN SER PHE ASP SER SEQRES 10 B 137 GLN SER TRP ASP ARG PHE GLY LYS ASN LEU VAL SER ALA SEQRES 11 B 137 LEU SER SER ALA GLY MET LYS HET HEM A 201 43 HET GOL A 202 6 HET GOL A 203 6 HET GOL A 204 12 HET 9J9 A 205 12 HET 9IX A 206 12 HET 9J9 A 207 12 HET 9J9 A 208 12 HET SO4 A 209 5 HET SO4 A 210 5 HET HEM B 201 43 HET GOL B 202 6 HET GOL B 203 6 HET GOL B 204 6 HET 9J9 B 205 12 HET 9IX B 206 12 HETNAM HEM PROTOPORPHYRIN IX CONTAINING FE HETNAM GOL GLYCEROL HETNAM 9J9 (6R)-4-HYDROXY-6-METHYL-3-(PROPAN-2-YL)CYCLOHEXA-2,4- HETNAM 2 9J9 DIEN-1-ONE HETNAM 9IX 2-METHYL-5-(PROPAN-2-YL)BENZENE-1,4-DIOL HETNAM SO4 SULFATE ION HETSYN HEM HEME HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL HETSYN 9IX THYMOQUINONE FORMUL 3 HEM 2(C34 H32 FE N4 O4) FORMUL 4 GOL 6(C3 H8 O3) FORMUL 7 9J9 4(C10 H14 O2) FORMUL 8 9IX 2(C10 H14 O2) FORMUL 11 SO4 2(O4 S 2-) FORMUL 19 HOH *208(H2 O) HELIX 1 AA1 GLY A 1 GLY A 11 1 11 HELIX 2 AA2 ASP A 12 TYR A 28 1 17 HELIX 3 AA3 PRO A 29 LYS A 32 5 4 HELIX 4 AA4 PHE A 35 VAL A 39 5 5 HELIX 5 AA5 SER A 42 MET A 49 1 8 HELIX 6 AA6 MET A 49 ALA A 70 1 22 HELIX 7 AA7 LEU A 76 MET A 86 1 11 HELIX 8 AA8 LYS A 87 SER A 90 5 4 HELIX 9 AA9 THR A 93 SER A 111 1 19 HELIX 10 AB1 ASP A 116 ALA A 134 1 19 HELIX 11 AB2 PHE B 2 ASP B 12 1 11 HELIX 12 AB3 ASP B 12 TYR B 28 1 17 HELIX 13 AB4 TYR B 28 ARG B 33 1 6 HELIX 14 AB5 SER B 42 SER B 48 1 7 HELIX 15 AB6 MET B 49 ALA B 70 1 22 HELIX 16 AB7 LEU B 76 GLN B 85 1 10 HELIX 17 AB8 MET B 86 SER B 90 5 5 HELIX 18 AB9 THR B 93 SER B 111 1 19 HELIX 19 AC1 ASP B 116 ALA B 134 1 19 LINK SG CYS A 73 C8 9IX A 206 1555 1555 1.71 LINK SG CYS B 73 C8 9IX B 206 1555 1555 1.76 CRYST1 58.358 67.565 67.825 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.017136 0.000000 0.000000 0.00000 SCALE2 0.000000 0.014801 0.000000 0.00000 SCALE3 0.000000 0.000000 0.014744 0.00000